Evidence map›Paper›PMID 29274805›Full record

ArticleBiological psychiatry2018

Prospective Validation That Subgenual Connectivity Predicts Antidepressant Efficacy of Transcranial Magnetic Stimulation Sites.

Anne Weigand, Andreas Horn, Ruth Caballero, Danielle Cooke, Adam P Stern, Stephan F Taylor, Daniel Press, Alvaro Pascual-Leone, Michael D Fox

4 registry-linked trialsOpen access · greenAbstract read
In one paragraph

Article in Biological psychiatry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 237 papers, 15 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
237citing papers in PubMed, 15 pooled it
15.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03845504 naterminatednot on this map

Evaluating the Efficacy and Tolerability of Targeted Transcranial Magnetic Stimulation in Youth

TypeinterventionalSponsorStanford UniversityRan2018 to 2019Enrolled4ConditionsDepressionArmsIntermittent Theta Burst Stimulation
NCT05465928 nacompletednot on this mapstarted 2022, after this paper: background citation

Neuroimaging Biomarker-Guided Personalized Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment for Major Depressive Episode in Adolescents and Young Adults with Mood Disorders: a Randomized, Double-Blind, Controlled Study

TypeinterventionalSponsorJiangsu Province Nanjing Brain HospitalRan2022 to 2024Enrolled219ConditionsMajor Depressive EpisodeArmsActive rTMS, Sham rTMS
NCT06490965 narecruitingnot on this mapstarted 2024, after this paper: background citation

Improving Obsessive-compulsive Disorder Treatments: from Lesions to Neuromodulation Targets

TypeinterventionalSponsorFundacao ChampalimaudRan2024 to 2026Enrolled32ConditionsObsessive-Compulsive DisorderArmsRepetitive Transcranial Magnetic Stimulation, Neuronavigation, Magnetic Resonance Imaging
NCT07775586 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Multicenter Randomized Controlled Trial Assessing Wearable Repetitive Transcranial Magnetic Stimulation for Home-Based Treatment of Depression

TypeinterventionalSponsorShanghai Mental Health CenterRan2026 to 2028Enrolled124ConditionsMajor Depressive DisorderArmsrTMS-Tiny Treatment, Sham Stimulation
3 · Its place in the literature

Who cites it

237 citing papers in PubMed, 15 syntheses or guidelines pooled it, 475 citations in OpenAlex.

  1. Heterogeneous brain alterations in treatment-resistant depression converge on common control networks.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Brain stimulation targets for chronic pain: Insights from meta-analysis, functional connectivity and literature review.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2024
    Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert Guidelines.Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology · 2021
    Guideline
  15. Pooled it
  16. Trial
  17. Target engagement in a head-to-head clinical trial of dysphoric versus anxiosomatic transcranial magnetic stimulation targets.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Trial
  18. Trial
  19. Trial
  20. Trial

177 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 3 countries.

Anne WeigandBerenson-Allen Center for Noninvasive Brain Stimulation, Department of Neurology, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, Massachusetts; Berlin School of Mind and Brain, Humboldt-Universität zu Berlin, Berlin, Germany.
Andreas HornBerenson-Allen Center for Noninvasive Brain Stimulation, Department of Neurology, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, Massachusetts; Department of Neurology, Movement Disorder and Neuromodulation Unit, Charité - Universitätsmedizin, Berlin, Germany.
Ruth CaballeroBerenson-Allen Center for Noninvasive Brain Stimulation, Department of Neurology, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, Massachusetts; Bioengineering and Telemedicine Center, ETSI Telecomunicación, Universidad Politécnica de Madrid, Madrid, Spain.
Danielle CookeBerenson-Allen Center for Noninvasive Brain Stimulation, Department of Neurology, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Adam P SternBerenson-Allen Center for Noninvasive Brain Stimulation, Department of Neurology, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, Massachusetts; Division of Cognitive Neurology, Department of Neurology, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Stephan F TaylorDepartment of Psychiatry, University of Michigan, Ann Arbor, Michigan.
Daniel PressBerenson-Allen Center for Noninvasive Brain Stimulation, Department of Neurology, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, Massachusetts; Division of Cognitive Neurology, Department of Neurology, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Alvaro Pascual-LeoneBerenson-Allen Center for Noninvasive Brain Stimulation, Department of Neurology, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, Massachusetts; Division of Cognitive Neurology, Department of Neurology, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, Massachusetts; Institut Guttmann, Universitat Autonoma de Barcelona, Madrid, Spain.
Michael D FoxBerenson-Allen Center for Noninvasive Brain Stimulation, Department of Neurology, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, Massachusetts; Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts; Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, Massachusetts. Electronic address: foxmdphd@gmail.com.
Berenson Allen Center for Noninvasive Brain Stimulation · USBeth Israel Deaconess Medical Center · USCharité - Universitätsmedizin Berlin · DEHarvard University · USHumboldt-Universität zu Berlin · DEUniversidad Politécnica de Madrid · ESUniversity of Michigan–Ann Arbor · US

Funding

HARVARD CLINICAL AND TRANSLATIONAL SCIENCE CENTER (UL1)UL1RR025758 · NCRR · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2008 to 2011
$91.4M
Michigan Institute for Clinical and Health Research (MICHR)UL1TR002240 · NCATS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LUMENG, JULIE C, MASHOUR, GEORGE ALEXANDER · 2017 to 2022
$54.9M
Michigan Institute for Clinical and Health Research (MCHR)UL1TR000433 · NCATS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MASHOUR, GEORGE ALEXANDER · 2012 to 2016
$49.9M
Using human brain connectivity to identify the causal neuroanatomical substrate of depression symptomsR01MH113929 · NIMH · BRIGHAM AND WOMEN'S HOSPITAL · PI MICHAEL D FOX · 2017 to 2026
$6.9M
A Storage Area Network for Structural and Functional Image AnalysisS10RR023401 · NCRR · MASSACHUSETTS GENERAL HOSPITAL · PI FISCHL, BRUCE · 2009 to 2009
$2.0M
SILICON GRAPHICS PRISM EXTREME 128P/1TBS10RR023043 · NCRR · MASSACHUSETTS GENERAL HOSPITAL · PI SORENSEN, ALMA GREGORY · 2006 to 2006
$1.5M
Use of Resting-State Networks to Predict the Ideal Site for Brain StimulationK23NS083741 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI FOX, MICHAEL D · 2013 to 2017
$980k
Role of functional brain connectivity on efficacy of TMS for depressionR21MH099196 · NIMH · BETH ISRAEL DEACONESS MEDICAL CENTER · PI PASCUAL-LEONE, ALVARO · 2013 to 2014
$491k
Imaging Biomarkers for TMS treatment of DepressionR21MH098174 · NIMH · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI TAYLOR, STEPHAN F · 2013 to 2014
$428k
NCATS NIH HHS UL1 TR000433NCATS NIH HHS UL1 TR002240NCRR NIH HHS S10 RR023043NCRR NIH HHS S10 RR023401NCRR NIH HHS UL1 RR025758NIMH NIH HHS R01 MH113929NIMH NIH HHS R21 MH098174NIMH NIH HHS R21 MH099196NINDS NIH HHS K23 NS083741
6 · The paper itself

Abstract

backgroundThe optimal target in the dorsolateral prefrontal cortex for treating depression with repetitive transcranial magnetic stimulation (rTMS) remains unknown. Better efficacy has been associated with stimulation sites that are 1) more anterior and lateral and 2) more functionally connected to the subgenual cingulate. Here we prospectively test whether these factors predict response in individual patients.

methodsA primary cohort (Boston, n = 25) with medication-refractory depression underwent conventional open-label rTMS to the left dorsolateral prefrontal cortex. A secondary cohort (Michigan, n = 16) underwent 4 weeks of sham followed by open-label rTMS for nonresponders (n = 12). In each patient, the location of the stimulation site was recorded with frameless stereotaxy. Connectivity between each patient's stimulation site and the subgenual cingulate was assessed using resting-state functional connectivity magnetic resonance imaging from a cohort of healthy subjects (n = 1000) and confirmed using connectivity from patients with depression (n = 38).

resultsIn our primary cohort, antidepressant efficacy was predicted by stimulation sites that were both more anterolateral (r = .51, p < .01) and more negatively correlated with the subgenual cingulate (r = -.55, p < .005). However, subgenual connectivity was the only independent predictor of response and the only factor to predict response to active (r = -.52, p < .05) but not sham rTMS in our secondary cohort.

conclusionsThis study provides prospective validation that functional connectivity between an individual's rTMS cortical target and the subgenual cingulate predicts antidepressant response. Implications for improving the cortical rTMS target for depression are discussed.

Indexed as

AdultAgedCohort StudiesFemaleGyrus CinguliHumansImage Processing, Computer-AssistedMagnetic Resonance ImagingMajor Depressive DisorderMaleMiddle AgedNeural PathwaysOxygenPrefrontal CortexPsychiatric Status Rating ScalesTranscranial Magnetic StimulationOxygenDepressionDorsolateral prefrontal cortexResting-state functional connectivitySubgenual cingulateTMSTranscranial magnetic stimulation

Identifiers

PMID29274805
PMCPMC6091227
OpenAlexW2767756464

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.